Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Lenvatinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Lenvatinib E7080 VEGFR2, VEGFR3, VEGFR1, PDGFR, FGFR1 Tyrosine kinases Approved Approved Selleck Chemicals S1164

Cell Line (34)
Cell LineAUCGI50
Huh70.822.97
SNU3980.8510.0
B10.8610.0
JHH40.887.02
Hep3B0.9210.0
MHCC97H0.9210.0
HepaRG0.9410.0
HCC.1.20.9510.0
Huh60.9510.0
JHH70.966.54
JHH60.9610.0
SNU4750.9610.0
SNU3540.9610.0
HCC.30.9610.0
SNU8860.9810.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it